{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:04:04Z","timestamp":1791230644923,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.mce.2003.10.044","type":"journal-article","created":{"date-parts":[[2003,12,5]],"date-time":"2003-12-05T11:42:11Z","timestamp":1070624531000},"page":"151-165","source":"Crossref","is-referenced-by-count":26,"title":["Towards selectively modulating mineralocorticoid receptor function: lessons from other systems"],"prefix":"10.1016","volume":"217","author":[{"given":"John D","family":"Baxter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Funder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W","family":"Apriletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2003.10.044_BIB1","doi-asserted-by":"crossref","first-page":"15161","DOI":"10.1073\/pnas.96.26.15161","article-title":"Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators","volume":"96","author":"An","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.mce.2003.10.044_BIB3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0896-6273(88)90136-5","article-title":"The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response","volume":"1","author":"Arriza","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/j.mce.2003.10.044_BIB4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/newbio230222a0","article-title":"Induction of puffs in polytene chromosomes of in vitro cultured salivary glands of Drosophila melanogaster by ecdysone and echysone analogues","volume":"230","author":"Ashburner","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/endo-94-4-998","article-title":"General presence of glucocorticoid receptors in mammalian tissues","volume":"94","author":"Ballard","year":"1974","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1073\/pnas.65.3.709","article-title":"The relationship between glucocorticoid binding and tyrosine aminotransferase induction in hepatoma tissue culture cells","volume":"65","author":"Baxter","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1073\/pnas.68.5.932","article-title":"Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells","volume":"68","author":"Baxter","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB8","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1073\/pnas.69.7.1892","article-title":"Role of DNA and specific cytoplasmic receptors in glucocorticoid action","volume":"69","author":"Baxter","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0960-0760(01)00052-8","article-title":"Selective modulation of thyroid hormone receptor action","volume":"76","author":"Baxter","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/en.143.2.517","article-title":"Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist","volume":"143","author":"Baxter","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2003.10.044_BIB12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/375377a0","article-title":"Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-\u03b1","volume":"375","author":"Bourguet","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1445-5994.1996.tb00600.x","article-title":"Primary hyperaldosteronism: a missed diagnosis in \u2018essential hypertensives\u2019?","volume":"26","author":"Brown","year":"1996","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB15","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1073\/pnas.79.14.4260","article-title":"Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains","volume":"79","author":"Carlstedt-Duke","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB16","unstructured":"Cato, A.C.B., Mink, S., Hartig, E., 1991. Gene activation mediated by glucocorticoid and mineralocorticoid receptors: the role of the steroid ligand. In: Bonvalet, J.P., Farman, N., Lombes, M., Rafestin-Oblin, M.E. (Eds.), Aldosterone: Fundamental Aspects. Colloque INSERM\/John Libbey Eurotext Ltd., Paris, pp. 23\u201332."},{"key":"10.1016\/j.mce.2003.10.044_BIB17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1074-5521(98)90168-5","article-title":"A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor","volume":"5","author":"Chiellini","year":"1998","journal-title":"Chem. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB18","first-page":"6","article-title":"Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB19","first-page":"253","article-title":"Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome, 1954","volume":"116","author":"Conn","year":"1990","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB20","doi-asserted-by":"crossref","unstructured":"Conn, J.W., Cohen, E.L., Rovner, D.R., 1985. In: Conn, J.W., Cohen, E.L., Rovner, D.R. (Eds.), Landmark article October 19, 1964: suppression of plasma renin activity in primary aldosteronism. Distinguishing primary from secondary aldosteronism in hypertensive disease. JAMA 253, 558\u2013566.","DOI":"10.1001\/jama.253.4.558"},{"key":"10.1016\/j.mce.2003.10.044_BIB21","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1101\/gad.12.21.3343","article-title":"Structure and specificity of nuclear receptor\u2013coactivator interactions","volume":"12","author":"Darimont","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.mce.2003.10.044_BIB22","first-page":"1","article-title":"On the biochemical mechanism of action of aldosterone","volume":"24","author":"Edelman","year":"1968","journal-title":"Rec. Prog. Horm. Res."},{"key":"10.1016\/j.mce.2003.10.044_BIB23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.mce.2003.10.044_BIB24","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism in the human mineralocorticoid receptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2003.10.044_BIB25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0092-8674(90)90343-D","article-title":"Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor","volume":"60","author":"Fawell","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.mce.2003.10.044_BIB26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1210\/endo-92-5-1429","article-title":"Evidence for a new class of corticosterone receptors in the rat kidney","volume":"92","author":"Feldman","year":"1973","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1126\/science.280.5370.1747","article-title":"Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors","volume":"280","author":"Feng","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.mce.2003.10.044_BIB28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2003.10.044_BIB29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.med.48.1.231","article-title":"Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance","volume":"48","author":"Funder","year":"1997","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB30","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1111\/j.1440-1681.1998.tb02300.x","article-title":"Aldosterone action: fact, failure and the future","volume":"25","author":"Funder","year":"1998","journal-title":"Clin. Exp. Pharmacol. Physiol. Suppl."},{"key":"10.1016\/j.mce.2003.10.044_BIB31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00060793-200006000-00006","article-title":"Eplerenone, a new mineralocorticoid antagonist: in vitro and in vivo studies","volume":"7","author":"Funder","year":"2000","journal-title":"Curr. Opin. Endocrinol. Diabet."},{"key":"10.1016\/j.mce.2003.10.044_BIB32","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1067\/mhj.2002.129971","article-title":"New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone","volume":"144","author":"Funder","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.mce.2003.10.044_BIB33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-4731(72)90052-0","article-title":"Specific aldosterone binding in rat kidney and parotid","volume":"3","author":"Funder","year":"1972","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.mce.2003.10.044_BIB34","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1096\/fasebj.4.14.2172062","article-title":"Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action","volume":"4","author":"Funder","year":"1990","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2003.10.044_BIB35","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/en.137.12.5264","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.mce.2003.10.044_BIB37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/ja005549c","article-title":"An inhibitor of the interaction of thyroid hormone receptor \u03b2 and glucocorticoid interacting protein 1","volume":"123","author":"Geistlinger","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mce.2003.10.044_BIB38","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1210\/jcem.80.12.8530580","article-title":"Primary aldosteronism (Conn\u2019s syndrome)","volume":"80","author":"Gittler","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2003.10.044_BIB39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1101\/gad.14.2.121","article-title":"The coregulator exchange in transcriptional functions of nuclear receptors","volume":"14","author":"Glass","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.mce.2003.10.044_BIB40","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1101\/gad.13.10.1329","article-title":"Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary\u2013thyroid axis, growth, and bone maturation","volume":"13","author":"Gothe","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.mce.2003.10.044_BIB44","doi-asserted-by":"crossref","unstructured":"Grover, G.J., Mellstrom, K., Ye, L., Malm, J., Li, Y.L., Bladh, L.G., Sleph, P.G., Smith, M.A., George, R., Vennstrom, B., Mookhtiar, K., Horvath, R., Speelman, J., Egan, D., Baxter, J.D., 2003. Selective thyroid hormone receptor-\u03b2 activation: a strategy for reduction of weight, cholesterol, and lipoprotein(a) with reduced cardiovascular liability. Proc. Natl. Acad. Sci. U.S.A., Jul 29 [Epub ahead of print].","DOI":"10.1073\/pnas.1633737100"},{"key":"10.1016\/j.mce.2003.10.044_BIB45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1096-7192(02)00009-4","article-title":"The NH(2)-terminal and carboxyl-terminal interaction in the human androgen receptor","volume":"75","author":"He","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mce.2003.10.044_BIB46","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.141.12.1589","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/318635a0","article-title":"Primary structure and expression of a functional human glucocorticoid receptor cDNA","volume":"318","author":"Hollenberg","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB48","doi-asserted-by":"crossref","first-page":"14274","DOI":"10.1074\/jbc.270.24.14274","article-title":"Ligand-independent and ligand-dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini","volume":"270","author":"Hollenberg","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB49","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1128\/MCB.20.16.6040-6050.2000","article-title":"A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy","volume":"20","author":"Iniguez-Lluhi","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB50","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1074\/jbc.M008384200","article-title":"Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway","volume":"276","author":"Jakacka","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB51","doi-asserted-by":"crossref","unstructured":"Jensen, E.V., Jacobson, H.L., 1960. Fate of steroidal estrogen in target tissues. In: Pineus, G., Vollmer, E.P. (Eds.), Biological Activities of Steroids in Relation to Cancer: Proceedings. Academic Press, New York, pp. 161\u2013178.","DOI":"10.1016\/B978-1-4832-2866-2.50015-5"},{"key":"10.1016\/j.mce.2003.10.044_BIB52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1073\/pnas.59.2.632","article-title":"A two-step mechanism for the interaction of estradiol with rat uterus","volume":"59","author":"Jensen","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)00064-7","article-title":"Combinatorial roles of the nuclear receptor corepressor in transcription and development","volume":"102","author":"Jepsen","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.mce.2003.10.044_BIB54","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/307745a0","article-title":"Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells","volume":"307","author":"King","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB55","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1128\/MCB.22.11.3698-3706.2002","article-title":"Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex","volume":"22","author":"Kitagawa","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB56","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/MCB.22.14.5222-5234.2002","article-title":"PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases","volume":"22","author":"Kotaja","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB57","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","article-title":"Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity","volume":"80","author":"Krozowski","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/me.2002-0258","article-title":"Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions","volume":"17","author":"Kumar","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0960-0760(00)00108-4","article-title":"Estrogen receptor pathways to AP-1","volume":"74","author":"Kushner","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB60","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/endo-109-6-1963","article-title":"Mineralocorticoid receptor-like aldosterone-binding protein in cell culture","volume":"109","author":"Lan","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB61","first-page":"184","article-title":"Thyroid hormone receptors: multiple forms, multiple possibilities","volume":"14","author":"Lazar","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2003.10.044_BIB62","doi-asserted-by":"crossref","first-page":"21467","DOI":"10.1074\/jbc.272.34.21467","article-title":"A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation","volume":"272","author":"Liden","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2003.10.044_BIB64","doi-asserted-by":"crossref","first-page":"35664","DOI":"10.1074\/jbc.M205608200","article-title":"A thyroid hormone antagonist that inhibits thyroid hormone action in vivo","volume":"277","author":"Lim","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB65","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1073\/pnas.92.26.12480","article-title":"Steroid receptor heterodimerization demonstrated in vitro and in vivo","volume":"92","author":"Liu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB66","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1210\/me.10.11.1399","article-title":"Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface","volume":"10","author":"Liu","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB67","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1210\/jc.85.8.2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2003.10.044_BIB68","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1210\/en.135.3.834","article-title":"The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase","volume":"135","author":"Lombes","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB69","doi-asserted-by":"crossref","unstructured":"Maglich, J.M., Sluder, A., Guan, X., Shi, Y., McKee, D.D., Carrick, K., Kamdar, K., Willson, T.M., Moore, J.T., 2001. Comparison of complete nuclear receptor sets from the human. Caenorhabditis elegans and Drosophila genomes. Genome Biol. 2, research0029.0021-research0029.0027.","DOI":"10.1186\/gb-2001-2-8-research0029"},{"key":"10.1016\/j.mce.2003.10.044_BIB70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/me.16.2.271","article-title":"TR surfaces and conformations required to bind nuclear receptor corepressor","volume":"16","author":"Marimuthu","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB71","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2003.10.044_BIB72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0960-0760(00)00109-6","article-title":"Development of peptide antagonists that target estrogen receptor\u2013cofactor interactions","volume":"74","author":"McDonnell","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0960-0760(00)00112-6","article-title":"From ligand to response: generating diversity in nuclear receptor coregulator function","volume":"74","author":"McKenna","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB74","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-73-5-952","article-title":"Diagnosis under random conditions of all disorders of the renin\u2013angiotensin\u2013aldosterone axis, including primary hyperaldosteronism","volume":"73","author":"McKenna","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2003.10.044_BIB75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1471-4892(01)00022-4","article-title":"Recent studies with eplerenone, a novel selective aldosterone receptor antagonist","volume":"1","author":"McMahon","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.mce.2003.10.044_BIB76","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2174\/1381612033455053","article-title":"Eplerenone, a new selective aldosterone blocker","volume":"9","author":"McMahon","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mce.2003.10.044_BIB77","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1073\/pnas.69.5.1146","article-title":"Ovalbumin messenger RNA of chick oviduct: partial characterization, estrogen dependence, and translation in vitro","volume":"69","author":"Means","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB78","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/312779a0","article-title":"Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells","volume":"312","author":"Miesfeld","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB79","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1016\/S0021-9258(18)91904-6","article-title":"Specific and nonspecific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro","volume":"243","author":"Munck","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB80","first-page":"E268","article-title":"Type I (mineralocorticoid) receptors in the guinea pig","volume":"267","author":"Myles","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB81","first-page":"F672","article-title":"Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells","volume":"259","author":"Naray-Fejes-Toth","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB82","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1021\/jm0201013","article-title":"Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment","volume":"45","author":"Nguyen","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor gamma","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB84","doi-asserted-by":"crossref","unstructured":"Norris, J.D., Chang, C., McDonnell, D.P., 2001. Estrogen receptor\u2013cofactor interactions as targets for novel drug discovery. In: Ernst Schering Research Found Workshop, pp. 181\u2013201.","DOI":"10.1007\/978-3-662-04645-6_10"},{"key":"10.1016\/j.mce.2003.10.044_BIB85","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.8382376","article-title":"Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element","volume":"259","author":"Pearce","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mce.2003.10.044_BIB86","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB87","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB88","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1074\/jbc.274.27.19441","article-title":"Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription","volume":"274","author":"Poukka","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB89","doi-asserted-by":"crossref","first-page":"14145","DOI":"10.1073\/pnas.97.26.14145","article-title":"Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)","volume":"97","author":"Poukka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2003.10.044_BIB90","first-page":"79","article-title":"Molecular chaperoning of steroid hormone receptors","volume":"77","author":"Pratt","year":"1996","journal-title":"EXS"},{"key":"10.1016\/j.mce.2003.10.044_BIB91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2003.10.044_BIB92","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","article-title":"DNA binding of the glucocorticoid receptor is not essential for survival","volume":"93","author":"Reichardt","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.mce.2003.10.044_BIB93","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0960-0760(97)00181-7","article-title":"Analysis of glucocorticoid signalling by gene targeting","volume":"65","author":"Reichardt","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB94","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/378681a0","article-title":"Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid","volume":"378","author":"Renaud","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB95","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.med.46.1.443","article-title":"The nuclear hormone receptor gene superfamily","volume":"46","author":"Ribeiro","year":"1995","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.mce.2003.10.044_BIB96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0960-0760(98)00029-6","article-title":"X-ray crystallographic and functional studies of thyroid hormone receptor","volume":"65","author":"Ribeiro","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB97","first-page":"351","article-title":"Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies","volume":"53","author":"Ribeiro","year":"1998","journal-title":"Rec. Prog. Horm. Res."},{"key":"10.1016\/j.mce.2003.10.044_BIB98","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1074\/jbc.M010195200","article-title":"Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor","volume":"276","author":"Ribeiro","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb04415.x","article-title":"The pathophysiology of aldosterone in the cardiovascular system","volume":"970","author":"Rocha","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mce.2003.10.044_BIB100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00003495-200262050-00001","article-title":"Rationale for the use of aldosterone antagonists in congestive heart failure","volume":"62","author":"Rocha","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.mce.2003.10.044_BIB101","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/en.141.10.3871","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB102","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB103","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0039-128X(99)00087-2","article-title":"Mineralocorticoid action","volume":"65","author":"Rogerson","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2003.10.044_BIB105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(02)00413-6","article-title":"Interdomain interactions in the mineralocorticoid receptor","volume":"200","author":"Rogerson","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0022-4731(72)90053-2","article-title":"Glucocorticoid and mineralocorticoid receptors for aldosterone","volume":"3","author":"Rousseau","year":"1972","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.mce.2003.10.044_BIB107","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/me.7.4.597","article-title":"Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor","volume":"7","author":"Rupprecht","year":"1993","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1677\/erc.0.0060487","article-title":"Prostate cancer: molecular biology of early progression to androgen independence","volume":"6","author":"Sadar","year":"1999","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2003.10.044_BIB109","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/en.137.10.4145","article-title":"High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes","volume":"137","author":"Sato","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0304-4165(68)90171-2","article-title":"Specificity and thermodynamic properties of the corticosteroid binding to a receptor of rat thymocytes in vitro","volume":"170","author":"Schaumburg","year":"1968","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2003.10.044_BIB111","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1068537","article-title":"Molecular determinants for the tissue specificity of SERMs","volume":"295","author":"Shang","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.mce.2003.10.044_BIB112","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1002\/j.1460-2075.1991.tb04953.x","article-title":"Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors","volume":"10","author":"Shemshedini","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2003.10.044_BIB113","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.mce.2003.10.044_BIB114","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1681.1996.tb02776.x","article-title":"Vascular localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme","volume":"23","author":"Smith","year":"1996","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1101\/gad.10.10.1271","article-title":"Intracellular receptors use a common mechanism to interpret signaling information at response elements","volume":"10","author":"Starr","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.mce.2003.10.044_BIB116","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/endo-99-1-260","article-title":"Glucocorticoid receptors: evidence for a second, non-glucocorticoid binding site","volume":"99","author":"Suthers","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000179735","article-title":"Stereospecific nuclear and cytosol aldosterone-binding proteins of various tissues","volume":"6","author":"Swaneck","year":"1969","journal-title":"Nephron"},{"key":"10.1016\/j.mce.2003.10.044_BIB118","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/S0021-9258(18)62766-8","article-title":"Stereospecific binding of aldosterone to renal chromatin","volume":"245","author":"Swaneck","year":"1970","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB119","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1210\/me.13.12.2108","article-title":"Opposing effects of corepressor and coactivators in determining the dose\u2013response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression","volume":"13","author":"Szapary","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB120","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1074\/jbc.M101806200","article-title":"Characterization of the physical interaction between estrogen receptor alpha and JUN proteins","volume":"276","author":"Teyssier","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB121","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1210\/en.141.9.3057","article-title":"The thyroid hormone receptor-\u03b2-selective agonist GC-1 differentially affects plasma lipids and cardiac activity","volume":"141","author":"Trost","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB122","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(00)01970-0","article-title":"Desethylamiodarone interferes with the binding of co-activator GRIP-1 to the beta 1-thyroid hormone receptor","volume":"481","author":"van Beeren","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2003.10.044_BIB123","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/378690a0","article-title":"A structural role for hormone in the thyroid hormone receptor","volume":"378","author":"Wagner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB124","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/MCB.18.3.1369","article-title":"The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor","volume":"18","author":"Wagner","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/me.15.3.398","article-title":"Hormone selectivity in thyroid hormone receptors","volume":"15","author":"Wagner","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1677\/erc.0.0070017","article-title":"Similarities and distinctions in the mode of action of different classes of antioestrogens","volume":"7","author":"Wakeling","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2003.10.044_BIB127","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev.biochem.68.1.559","article-title":"Nuclear-receptor ligands and ligand-binding domains","volume":"68","author":"Weatherman","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.mce.2003.10.044_BIB128","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/me.9.4.443","article-title":"Tamoxifen activation of the estrogen receptor\/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens","volume":"9","author":"Webb","year":"1995","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.044_BIB129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0960-0760(02)00270-4","article-title":"Design of thyroid hormone receptor antagonists from first principles","volume":"83","author":"Webb","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2003.10.044_BIB130","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1074\/jbc.M208501200","article-title":"Differential SERM effects on corepressor binding dictate ERalpha activity in vivo","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB131","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.mce.2003.10.044_BIB132","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/307747a0","article-title":"Nuclear localization of unoccupied oestrogen receptors","volume":"307","author":"Welshons","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB133","doi-asserted-by":"crossref","first-page":"23824","DOI":"10.1074\/jbc.272.38.23824","article-title":"Identification and characterization of the AF-1 transactivation domain of thyroid hormone receptor \u03b21","volume":"272","author":"Wilkinson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB134","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1210\/jc.80.11.3145","article-title":"Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2003.10.044_BIB135","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/jc.80.7.2263","article-title":"A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2003.10.044_BIB136","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0021-9258(17)38183-8","article-title":"Separation of the hormone- and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis","volume":"253","author":"Wrange","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2003.10.044_BIB137","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/415813a","article-title":"Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR\u03b1","volume":"415","author":"Xu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.mce.2003.10.044_BIB138","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mce.2003.10.044_BIB139","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2003.10.044_BIB140","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism--changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.044_BIB141","first-page":"E883","article-title":"The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis","volume":"271","author":"Young","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2003.10.044_BIB142","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200208000-00002","article-title":"Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system","volume":"20","author":"Young","year":"2002","journal-title":"J. Hypertens."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720703003939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720703003939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:49:55Z","timestamp":1682610595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720703003939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":142,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0303720703003939"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2003.10.044","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}